XIAOYU XU

No ORCID on file · 34 papers in corpus · active 2008-2024

Study types

  • article 17
  • other 2

Condition tags

  • endometriosis 19
  • infertility 1
other 2024
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1492098

INTRODUCTION: Macranthoidin B is one of the primary and unique triterpenoid saponin metabolites from Lonicera macranthoides Hand. -Mazz, which is used to treat endometriosis (EMS) in traditional Chinese medicine. However, the effect of macr…

article 2023
Life sciences ·doi:10.1016/j.lfs.2023.121921

AIMS: With an ambiguous anti-proliferative mechanism, the combination of ferulic acid, ligustrazine, and tetrahydropalmatine (FLT) shows good anti-endometriosis (EMS) activity. In EMS, the expression of Notch pathway and its role in prolife…

article 2021
PeerJ ·doi:10.7717/peerj.11045

BACKGROUND: Endometriosis is a common gynecological disease among women in their reproductive years. Although much effort has been made, the pathogenesis of this disease and the detailed differences between eutopic endometrial cells and ect…

article 2018
Frontiers in pharmacology ·doi:10.3389/fphar.2018.00811

Jiawei Foshou San (JFS) is the new formula originated from classic Foshou San formula, composed with ligustrazine, ferulic acid and tetrahydropalmatine. Previously JFS inhibited the growth of endometriosis with unclear mechanism, especially…

article 2018
2017
International journal of biological sciences ·doi:10.7150/ijbs.17751

Catalpol and puerarin are two monomers of Rehmannia glutinosa and Lobed Kudzuvine Root, which are two herbs commonly used together in ancient prescriptions of traditional Chinese medicine for cerebral ischemia. Our previous study shows that…

2014
International journal of biological sciences ·doi:10.7150/ijbs.8571

Catalpol and puerarin are active ingredients isolated from Rehmannia glutinosa Libosch and Radix Puerariae, respectively. They are popular in research for their poly-pharmacological effects. This research focused on effect of anti-stroke by…

article 2014
Journal of ethnopharmacology ·doi:10.1016/j.jep.2013.12.047

Ethnopharmacological relevanceFerulic acid (FA), ligustrazine (LZ) and tetrahydropalmatine (THP) are separately isolated from Chinese Angelica, Szechwan Lovage Rhizome and Rhizoma in the Jiawei-Foshou-San formula, a popular traditional Chin…

article 2012

A lot of clinical observation and basic research suggest that endometrial exist stem cells with high proliferation,self-renewal and differentiation potential.Although in recent years,research on endometrial stem cell isolation and identific…

article 2011

Aim To explore the effect and the mechanism of Jiawei Foshousan on angiogenesis of endometriosis(EMS)in rats.Methods The rat model of EMS was established by surgical implant of the endometrial tissue which belong to its body.We explored mic…

article 2011
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica ·doi:10.4268/cjcmm20112121

OBJECTIVE: To explore the effect and mechanism of Jiawei Foshou San on the accretion ectopic endometrium of rats. METHOD: Endometriosis model was established by surgical implant of endometrial tissue which belongs to its body in rats. Jiawe…

article 2011

Objective: To explore the effect and mechanism of Jiawei Foshou San on the accretion ectopic endometrium of rats.Method: Endometriosis model was established by surgical implant of endometrial tissue which belongs to its body in rats.Jiawei …

article 2010
Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials

OBJECTIVE: To study the inhibitory effect on estradiol (E2) production of endometriosis by medicated serum of Jiawei Sanleng pill (SLW) and approach the mechanism of inducing apoptosis of human endometrial cells of endometriosis by medicate…

article 2010

Objective:To study the inhibitory effect on estradiol(E2) production of endometriosis by medicated serum of Jiawei Sanleng pill(SLW) and approach the mechanism of inducing apoptosis of human endometrial cells of endometriosis by medicated s…

other 2010
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica ·doi:10.4268/cjcmm20101213

OBJECTIVE: To study the inhibitory effect of medicated serum of SLW on estrogen production and to approach on the key mechanism of SLW in inhibiting the invasion ability of endometrial cells of endometriosis. METHOD: First, the model of eu…

article 2010

Objective: To study the inhibitory effect of medicated serum of SLW on estrogen production and to approach on the key mechanism of SLW in inhibiting the invasion ability of endometrial cells of endometriosis.Method: First,the model of eutop…

article 2009

AIM To study the effect of Jiawei Sanlengwan(SLW) on the secretion level of estradiol(E2) and the expression and secretion level of vascular endothelial growth factor(VEGF) in endometrial cells of endometriosis,and then to approach the mech…

article 2009
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

OBJECTIVE: To explore the effect of Sanlengwan (SLW) on adhesion molecules expression and the accretion in ectopic endometrium of rats. METHOD: Endometriosis was established by surgical implant of endometrial tissue which belong to its body…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…

2009

The invention relates to a traditional Chinese medicine composition of curing endometriosis uterine, which is characterized by comprising 50 to 2000mg of ligustrazine (or ligustrazine phosphate and Chuangxiongzine Hydrochlorid), 100 to 4000…